Shuji Hiramoto1, Ayako Kikuchi2, Hori Tetsuso3, Akira Yoshioka2, Yasushi Kohigashi4, Isseki Maeda5. 1. Department of Clinical Oncology and Palliative Medicine, Mitsubishi Kyoto Hospital, Katsuragoshocho 1, Nishikyo-ku, Kyoto, Japan. otomari1rx.8@gmail.com. 2. Department of Clinical Oncology and Palliative Medicine, Mitsubishi Kyoto Hospital, Katsuragoshocho 1, Nishikyo-ku, Kyoto, Japan. 3. Department of Respiratory Surgeries, Mitsubishi Kyoto Hospital, Kyoto, Japan. 4. Department of Radiology, Mitsubishi Kyoto Hospital, Kyoto, Japan. 5. Gratia Hospital Hospice, Minoh, Japan.
Abstract
BACKGROUND: Bleeding and obstruction are common localized symptoms in patients with unresectable gastric cancer. Although there are several reports about surgical and endoscopic therapies for gastric cancer, there are few regarding palliative radiation therapy. METHODS: We retrospectively analyzed data for 23 gastric cancer patients who underwent palliative radiation between April 2006 and March 2014, with either localized bleeding (n = 18) or upper gastric obstruction (n = 10). RESULTS: The median (range) total dose and fraction (Fr) of radiotherapy (RT) were 42 (18-60) Gy and 20 (9-30) Fr, respectively. The response rates were 88.8% (bleeding) and 80% (obstruction). The median event-free survival times of the bleeding and obstruction groups from the start of radiation were 103 and 104 days, respectively. Adverse events with RT and chemo-radiotherapy (CRT) were grade 2 nausea (n = 4) and grade 2 esophagitis (n = 3) and grade 2 neutropenia (n = 3). In univariate analysis, the antrum as the gastric primary site (p = 0.063) and peritoneal metastasis (p = 0.054) occurred more frequently in the non-responders (n = 4) than the responders (n = 19).
BACKGROUND:Bleeding and obstruction are common localized symptoms in patients with unresectable gastric cancer. Although there are several reports about surgical and endoscopic therapies for gastric cancer, there are few regarding palliative radiation therapy. METHODS: We retrospectively analyzed data for 23 gastric cancerpatients who underwent palliative radiation between April 2006 and March 2014, with either localized bleeding (n = 18) or upper gastric obstruction (n = 10). RESULTS: The median (range) total dose and fraction (Fr) of radiotherapy (RT) were 42 (18-60) Gy and 20 (9-30) Fr, respectively. The response rates were 88.8% (bleeding) and 80% (obstruction). The median event-free survival times of the bleeding and obstruction groups from the start of radiation were 103 and 104 days, respectively. Adverse events with RT and chemo-radiotherapy (CRT) were grade 2 nausea (n = 4) and grade 2 esophagitis (n = 3) and grade 2 neutropenia (n = 3). In univariate analysis, the antrum as the gastric primary site (p = 0.063) and peritoneal metastasis (p = 0.054) occurred more frequently in the non-responders (n = 4) than the responders (n = 19).
Authors: Jeremy Tey; Michael F Back; Thomas P Shakespeare; Rahul K Mukherjee; Jiade J Lu; Khai Mun Lee; Lea Choung Wong; Cheng Nang Leong; Ming Zhu Journal: Int J Radiat Oncol Biol Phys Date: 2006-11-21 Impact factor: 7.038
Authors: Michelle M Kim; Vishal Rana; Nora A Janjan; Prajnan Das; Alexandria T Phan; Marc E Delclos; Paul F Mansfield; Jaffer A Ajani; Christopher H Crane; Sunil Krishnan Journal: Acta Oncol Date: 2008 Impact factor: 4.089
Authors: T J Savides; D M Jensen; J Cohen; G M Randall; T O Kovacs; E Pelayo; S Cheng; M E Jensen; H Y Hsieh Journal: Endoscopy Date: 1996-02 Impact factor: 10.093